<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Loss of chromosome 5 or deletion of 5q is commonly seen in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Loss of EGR1, located on 5q31, has been postulated as contributing to the pathology of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in patients with -5/del(5q) </plain></SENT>
<SENT sid="2" pm="."><plain>We report on the first case of a patient with a novel apparent balanced translocation between chromosomes 5 and 22 at breakpoints 5q31 and 22q11.2 </plain></SENT>
<SENT sid="3" pm="."><plain>Fluorescence in situ hybridization using a probe of EGR1 detected a cryptic deletion masked by the translocation </plain></SENT>
</text></document>